Literature DB >> 12207150

Prevalence of multiple sclerosis in Austria. Results of a nationwide survey.

U Baumhackl1, G Eibl, U Ganzinger, H P Hartung, B Mamoli, K P Pfeiffer, F Fazekas, K Vass.   

Abstract

The epidemiology of multiple sclerosis (MS) in Austria is almost unknown. We evaluated the prevalence of MS in Austria using data from questionnaires completed by neurologists, comprising information on a total of 1,006 MS patients who attended 30 out-patient specialized clinics nationwide. Additional data were collected from 2,414 MS patients, who received questionnaires from the Austrian MS Society or their doctor. A novel extrapolation model, based on frequencies of patients visits at MS clinics, was used to estimate the overall prevalence of MS. Considering either disability or the course of the disease, the prevalence of MS patients in Austria was estimated to be 98.5 per 100,000 people. The prevalence of MS in Austria was found to be similar to that of other countries in Central Europe. Epidemiological studies, such as this, provide a unique source of data from which key features of a disease and its impact on patients may be examined. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 12207150     DOI: 10.1159/000065640

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  7 in total

Review 1.  Neutralizing antibodies to interferon-beta and other immunological treatments for multiple sclerosis: prevalence and impact on outcomes.

Authors:  Florian Deisenhammer
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

Review 2.  [Subcutaneous interferon-beta-1a in the treatment of multiple sclerosis].

Authors:  Elisabeth Fertl; Martin Krichmayr
Journal:  Wien Med Wochenschr       Date:  2008

3.  [Health care costs of multiple sclerosis in Austria. Cross-sectional study including consideration of quality of life].

Authors:  U Ganzinger; C Badelt; K Vass; S Strasser-Fuchs; F Fazekas; T Berger; F Dahlke
Journal:  Nervenarzt       Date:  2004-10       Impact factor: 1.214

4.  Geomagnetic disturbances may be environmental risk factor for multiple sclerosis: an ecological study of 111 locations in 24 countries.

Authors:  Seyed Aidin Sajedi; Fahimeh Abdollahi
Journal:  BMC Neurol       Date:  2012-09-24       Impact factor: 2.474

Review 5.  Incidence and prevalence of multiple sclerosis in Europe: a systematic review.

Authors:  Elaine Kingwell; James J Marriott; Nathalie Jetté; Tamara Pringsheim; Naila Makhani; Sarah A Morrow; John D Fisk; Charity Evans; Sarah Gabrielle Béland; Sophie Kulaga; Jonathan Dykeman; Christina Wolfson; Marcus W Koch; Ruth Ann Marrie
Journal:  BMC Neurol       Date:  2013-09-26       Impact factor: 2.474

6.  Long Term Clinical Prognostic Factors in Relapsing-Remitting Multiple Sclerosis: Insights from a 10-Year Observational Study.

Authors:  Gabriel Bsteh; Rainer Ehling; Andreas Lutterotti; Harald Hegen; Franziska Di Pauli; Michael Auer; Florian Deisenhammer; Markus Reindl; Thomas Berger
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

7.  A Systematic Assessment of Prevalence, Incidence and Regional Distribution of Multiple Sclerosis in Bavaria From 2006 to 2015.

Authors:  Tanja Daltrozzo; Alexander Hapfelmeier; Ewan Donnachie; Antonius Schneider; Bernhard Hemmer
Journal:  Front Neurol       Date:  2018-10-30       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.